Simplified assessment of antiretroviral adherence and prediction of virological efficacy in HIV-infected patients in Cambodia

AIDS Research and Treatment

Volumn 2010, Issue , 2010, Pages

  Segeral, Olivier ^a   Madec, Yoann ^b   Ban, Boroath ^c   Ouk, Vara ^c   Hak, Chan Roeurn ^c   Le Tiec, Clotilde ^a   Nerrienet, Eric ^d   Goujard, Cécile ^a   Taburet, Anne Marie ^a   Delfraissy, Jean Francois ^a   Fontanet, Arnaud ^b  

^a BICÊTRE HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

^c Hopital Calmette   (Cambodia)

^d INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79954422325     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2010/142076     Document Type: Article

References (37)

1. Palella F. J. Jr., Delaney K. M., Moorman A. C., Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. The New England Journal of Medicine 1998 338 853 860 (Pubitemid 28135961)
2. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress Report 2008 Geneva, Switzerland WHO, UNAIDS, UNICEF
3. Laurent C., Diakhate N., Gueye N. F., The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS 2002 16 10 1363 1370 10.1097/00002030-200207050-00008 2-s2.0-0037024756 (Pubitemid 34722068)
4. Galvao J., Access to antiretroviral drugs in Brazil. The Lancet 2002 360 9348 1862 1865 10.1016/S0140-6736(02)11775-2 2-s2.0-0037038826 (Pubitemid 35449428)
5. Phanuphak P., ppraphan@chula.ac.th Antiretroviral treatment in resource-poor settings: what can we learn from the existing programmes in Thailand? AIDS 2004 18 supplement 3 S33 S38 2-s2.0-0042329128 10.1097/00002030-200406003-00007 (Pubitemid 39037457)
6. Laurent C., Kouanfack C., Koulla-Shiro P. S., Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. The Lancet 2004 364 9428 29 34 2-s2.0-0035816360 10.1016/S0140-6736(04)16586-0 (Pubitemid 38968622)
7. Ferradini L., msffr.comed@online.com.kh Jeannin A., Pinoges L., Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. The Lancet 2006 367 9519 1335 1342 2-s2.0-3042781178 10.1016/S0140-6736(06)68580-2
8. Katzenstein D., Laga M., Moatti J.-P., The evaluation of the HIV/AIDS drug access initiatives in Cote d'Ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa. AIDS 2003 17 supplement 3 S1 S4 2-s2.0-0037038826 (Pubitemid 36951663)
9. Calmy A., acalmy@stvincents.com.au Pinoges L., Szumilin E., Zachariah R., Ford N., Ferradini L., Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS 2006 20 8 1163 1169 2-s2.0-0037072066 10.1097/01.aids.0000226957.79847.d6 (Pubitemid 43786105)
10. Ivers L. C., livers@partners.org Kendrick D., Doucette K., Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clinical Infectious Diseases 2005 41 2 217 224 2-s2.0-0033008399 10.1086/431199 (Pubitemid 40962502)
11. Akileswaran C., Lurie M. N., Mark-Lurie@Brown.edu Flanigan T. P., Mayer K. H., Lessons learned from use of highly active antiretroviral therapy in Africa. Clinical Infectious Diseases 2005 41 3 376 385 2-s2.0-0033612928 10.1086/431482 (Pubitemid 41022117)
12. Moatti J.-P., Spire B., Kazatchkine M., Drug resistance and adherence to HIV/AIDS antiretroviral treatment: against a double standard between the north and the south. AIDS 2004 18 supplement 3 S55 S61 2-s2.0-0035696398 10.1097/00002030-200406003-00011
13. Galárraga O., O'Brien M. E., Gutiérrez J. P., Forecast of demand for antiretroviral drugs in low and middle-income countries: 2007-2008. AIDS 2007 21 supplement 4 S97 S103 2-s2.0-34447342574 10.1097/01.aids. 0000279712.32051.29
14. Harrigan P. R., Hogg R. S., Dong W. W. Y., Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. Journal of Infectious Diseases 2005 191 3 339 347 10.1086/427192 2-s2.0-19944431012 (Pubitemid 40139758)
15. Carrieri M. P., Raffi F., Lewden C., Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study. Antiviral Therapy 2003 8 6 585 594 2-s2.0-9144232263 (Pubitemid 38057104)
16. Sethi A. K., Celentano D. D., Gange S. J., Moore R. D., Gallant J. E., Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clinical Infectious Diseases 2003 37 8 1112 1118 10.1086/378301 2-s2.0-0142218458 (Pubitemid 37323668)
17. Harries A. D., Schouten E. J., Libamba E., Scaling up antiretroviral treatment in resource-poor settings. The Lancet 2006 367 9525 1870 1872 10.1016/S0140-6736(06)68809-0 2-s2.0-33744782288 (Pubitemid 43833194)
18. Goujard C., Bernard N., Sohier N., Impact of a patient education program on adherence to HIV medication: a randomized clinical trial. Journal of Acquired Immune Deficiency Syndromes 2003 34 2 191 194 10.1097/00126334-200310010-00009 2-s2.0-0141958209 (Pubitemid 37248916)
19. Marchand C., Himmich H., Maaroufi A., Sohier N., Chambon J. F., Gagnayre R., Implementation and assessment of an HIV treatment training program (2000-2001) for patients in Casablanca (Morocco). Sante 2005 15 2 73 80 2-s2.0-23244443351 (Pubitemid 41098051)
20. Iguenane J., Marchand C., Bodelot D., Implementation of therapeutic education programmes for patients living with HIV in four low-income countries: an evaluative approach. Sante Publique 2007 19 4 323 333 2-s2.0-0141958209
21. Nemes M. I. B., mibnemes@usp.br Carvalho H. B., Souza M. F. M., Antiretroviral therapy adherence in Brazil. AIDS 2004 18 supplement 3 S15 S20 2-s2.0-0036245622 10.1097/00002030-200406003-00004 (Pubitemid 39037454)
22. Glass T. R., De Geest S., Sabina.degeest@unibas.ch Weber R., Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes 2006 41 3 385 392 2-s2.0-0034027217 10.1097/01.qai.0000186371.95301.52
23. Giordano T. P., Guzman D., Clark R., Charlebois E. D., Bangsberg D. R., Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clinical Trials 2004 5 2 74 79 10.1310/JFXH-G3X2- EYM6-D6UG 2-s2.0-2542565696 (Pubitemid 38697081)
24. Amico K. R., Fisher W. A., Cornman D. H., Visual analog scale of ARV adherence: association with 3-day self-report and adherence barriers. Journal of Acquired Immune Deficiency Syndromes 2006 42 455 459 (Pubitemid 44050893)
25. Duran S., Peytavin G., Carrieri P., The detection of non-adherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determination. AIDS 2003 17 7 1096 1099 10.1097/00002030- 200305020-00025 2-s2.0-0037541190 (Pubitemid 36549728)
26. Alexander C. S., Asselin J. J., Ting L. S. L., Antiretroviral concentrations in untimed plasma samples predict therapy outcome in a population with advanced disease. Journal of Infectious Diseases 2003 188 4 541 548 10.1086/376835 2-s2.0-0041941506 (Pubitemid 37011806)
27. Duong M., Piroth L., Peytavin G., Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response. Clinical Infectious Diseases 2001 33 3 386 392 10.1086/321876 2-s2.0-0034920479 (Pubitemid 32664847)
28. Arnsten J. H., Demas P. A., Farzadegan H., Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clinical Infectious Diseases 2001 33 8 1417 1423 10.1086/323201 2-s2.0-0035887958 (Pubitemid 32955198)
29. Hugen P. W. H., Langebeek N., Burger D. M., Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. Journal of Acquired Immune Deficiency Syndromes 2002 30 3 324 334 2-s2.0-0036639969 (Pubitemid 34774081)
30. Romanelli F., Empey K., Pomeroy C., Macrocytosis as an indicator of medication (zidovudine) adherence in patients with HIV infection. AIDS Patient Care and STDs 2002 16 9 405 411 10.1089/108729102760330245 2-s2.0-0036742740
31. Rouet F., rouet@aviso.ci Ekouevi D. K., Chaix M.-L., Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. Journal of Clinical Microbiology 2005 43 6 2709 2717 2-s2.0-0142156007 10.1128/JCM.43.6.2709-2717.2005 (Pubitemid 40827943)
32. Ferradini L., msffr.comed@online.com.kh Laureillard D., Prak N., Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia. AIDS 2007 21 17 2293 2301 2-s2.0-29244432755 10.1097/QAD.0b013e32828cc8b7 (Pubitemid 350287455)
33. Spire B., spire@marseille.inserm.fr Carrieri P., Sopha P., Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment. Antiviral Therapy 2008 13 5 697 703 2-s2.0-0035947280
34. Oyugi J. H., Byakika-Tusiime J., Ragland K., Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 2007 21 8 965 971 2-s2.0-0036191004 10.1097/QAD.0b013e32802e6bfa (Pubitemid 46684328)
35. Mee P., paul.mee@ctu.mrc.ac.uk Fielding K. L., Charalambous S., Churchyard G. J., Grant A. D., Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS 2008 22 15 1971 1977 2-s2.0-34547795900 10.1097/QAD.0b013e32830e4cd8
36. Phillips A. N., a.phillips@pcps.ucl.ac.uk Pillay D., Miners A. H., Bennett D. E., Gilks C. F., Lundgren J. D., Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model. The Lancet 2008 371 9622 1443 1451 2-s2.0-35448977297 10.1016/S0140-6736(08)60624-8 (Pubitemid 351635534)
37. Ramadhani H. O., Thielman N. M., Landman K. Z., Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clinical Infectious Diseases 2007 45 11 1492 1498 2-s2.0-33646757550 10.1086/522991 (Pubitemid 351411882)